| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $265.78M | - | |
| Dir | 390.7K | $87.77M | - | |
| CEO | 152.2K | $34.19M | - | |
| VP | 72.6K | $16.32M | - | |
| CFO | 59.6K | $13.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2023 | Pearce Samantha76 | SVP, Head Of Europe &Internat | Sale+OE | 531 | $157.26 | $83,505.06 | -4.5% | -12.6% | -21.4% | |
| Feb 1, 2023 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,000 | $155.79 | $155,790.00 | -0.3% | -13.1% | -21.6% | |
| Jan 3, 2023 | Cozadd Bruce C59 | Chairman &CEO | Sell | 3,000 | $159.86 | $479,590.00 | -0.4% | -7.0% | -19.8% | |
| Jan 3, 2023 | Pearce Samantha76 | SVP, Head Of Europe &Internat | Sale+OE | 531 | $159.59 | $84,742.29 | -4.5% | -7.0% | -19.8% | |
| Dec 21, 2022 | Gala Renee D | EVP &Chief Financial Officer | Sell | 2,635 | $160.00 | $421,600.00 | -7.5% | -11.8% | -23.6% | |
| Dec 13, 2022 | Pearce Samantha76 | SVP, Head Of Europe &Internat | Sale+OE | 531 | $155.45 | $82,543.95 | -4.5% | -12.0% | -17.6% | |
| Dec 9, 2022 | Iannone Robert50 | EVP, Global Head Of R&D | Sell | 1,844 | $151.54 | $279,439.76 | -4.8% | -9.3% | -20.8% | |
| Dec 5, 2022 | Carr Patricia65 | SVP, Chief Accounting Officer | Sell | 63 | $152.06 | $9,579.98 | -1.1% | -5.4% | -19.5% | |
| Dec 2, 2022 | Cook Jennifer E.60 | Director | Sell | 420 | $154.68 | $64,965.56 | -7.1% | -8.2% | -24.3% | |
| Dec 2, 2022 | Smith Mark Douglas68 | Director | Sell | 420 | $154.68 | $64,965.85 | -7.1% | -8.2% | -24.3% |